1684P Cardiovascular events with immune checkpoint inhibitors in melanoma or NSCLC: A systematic review and meta-analysis

Mario Mandalà; Cecilia Becattini; F. Roila; Giancarlo Agnelli; Michela Giustozzi

doi:10.1016/j.annonc.2021.08.1656

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis

Michela Giustozzi, Cecilia Becattini, Fausto Roila, Giancarlo Agnelli, Mario Mandalà

Article2019

Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Jong Yeob Kim, Andreas Kronbichler, Michael Eisenhut, Sung Hwi Hong, Jeonghyun Kang, Jae Il Shin, Gabriele Gamerith

Article2024

Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis

Laura Pala, Eleonora Pagan, Isabella Sala, Chiara Oriecuia, Matteo Oliari, Tommaso De Pas, Claudia Specchia, Emilia Cocorocchio, Emma Zattarin, Giovanna Rossi, Chiara Catania, Giovanni Luca Ceresoli, Daniele Laszlo, Jacopo Canzian, Elena Valenzi, Giuseppe Viale, Richard D. Gelber, Alberto Mantovani, Vincenzo Bagnardi, Fabio Conforti

Article2024

Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

Shufu Hou, Dandan Song, Ruiqi Hao, Linchuan Li, Yun Zhang, Jian Kang Zhu

Article2010

Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis

Cecilia Becattini, Maria Cristina Vedovati, Walter Ageno, Francesco Dentali, Giancarlo Agnelli